Back to Search Start Over

An atypical relapse of acute myeloid leukemia diagnosed by 18F-FDG PET/CT.

Authors :
UCL - (MGD) Laboratoire de biologie clinique
UCL - (MGD) Service de médecine nucléaire
UCL - (MGD) Service d'hématologie
UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - SSS/IRSS - Institut de recherche santé et société
UCL - (SLuc) Service de médecine nucléaire
Schollaert, Pascaline
Loosen, Claire
André, Marc
Chatelain, Bernard
Krug, Bruno
UCL - (MGD) Laboratoire de biologie clinique
UCL - (MGD) Service de médecine nucléaire
UCL - (MGD) Service d'hématologie
UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - SSS/IRSS - Institut de recherche santé et société
UCL - (SLuc) Service de médecine nucléaire
Schollaert, Pascaline
Loosen, Claire
André, Marc
Chatelain, Bernard
Krug, Bruno
Source :
Clinical Nuclear Medicine, Vol. 37, no. 10, p. 1018-1021 (2012)
Publication Year :
2012

Abstract

Extramedullary relapse of acute myeloid leukemia (AML) after stem-cell transplant is very rare and often remains a diagnostic challenge. Although the diagnostic value of PET/CT has not been evaluated thoroughly in leukemia, it might be useful for detecting these focal localizations. We presented a case of a 58-year-old man, with a prior history of localized bladder cancer and a secondary AML, referred to our hospital with important thoracic backaches. PET/CT revealed the presence of meningeal carcinomatosis at the thoracic level, as well as lymph nodes, and muscular and bone metastases. Immunophenotyping of the cerebrospinal fluid aspirate showed a relapse of AML.

Details

Database :
OAIster
Journal :
Clinical Nuclear Medicine, Vol. 37, no. 10, p. 1018-1021 (2012)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1130505964
Document Type :
Electronic Resource